Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastasis From Malignant Tumor of Prostate (Disorder)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06931340
What this trial is testing

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Who this might be right for
Castration-Sensitive Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
Alliance for Clinical Trials in Oncology 1,260
Testing effectiveness (Phase 2)Study completedNCT00466440
What this trial is testing

Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Eli Lilly and Company 108
Post-approval studies (Phase 4)Study completedNCT00172016
What this trial is testing

Evaluate the Efficacy and Tolerability of Zoledronic Acid in Patients With Metastatic Prostate Cancer Who Can be Treated With a Group of Medications Known as Bisphosphonates

Who this might be right for
Prostate Cancer With at Least One Bone Lesion in Patients Receiving Hormonal Therapy and Treatment With Bisphosphonates is Indicated
Novartis Pharmaceuticals 43
Early research (Phase 1)Looking for participantsNCT07145177
What this trial is testing

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer
University of California, San Francisco 30
Very early researchStudy completedNCT06359821
What this trial is testing

Evaluate Safety, Whole-Body Distribution and Radiation Dosimetry in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sichuan University 4
Testing effectiveness (Phase 2)Ended earlyNCT00494338
What this trial is testing

Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sanofi 6
Not applicableLooking for participantsNCT07209176
What this trial is testing

Physician- and Patient-based Barriers to NGS Testing

Who this might be right for
Metastatic Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 256
Testing effectiveness (Phase 2)Ended earlyNCT03360721
What this trial is testing

Apalutamide, Abiraterone Acetate, and Prednisone in Treating Participants With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma Without Neuroendocrine DifferentiationStage IV Prostate Cancer AJCC v8+2 more
M.D. Anderson Cancer Center 7
Not applicableActive Not RecruitingNCT02730338
What this trial is testing

INTense ExeRcise for SurviVAL Among Men with Metastatic Prostate Cancer (INTERVAL - GAP4)

Who this might be right for
Metastatic Prostate Cancer
Movember Foundation 866
Not applicableStudy completedNCT02376296
What this trial is testing

Observational Study of Docetaxel Exposure in Metastatic Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Saladax Biomedical, Inc. 35
Not applicableUnknownNCT01168141
What this trial is testing

Window Study of ZD4054 in Metastatic Prostate Cancer

Who this might be right for
Prostate CancerMetastasis
The Christie NHS Foundation Trust 30
Testing effectiveness (Phase 2)Study completedNCT00814788
What this trial is testing

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 24
Early research (Phase 1)Not Yet RecruitingNCT07756593
What this trial is testing

Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate Cancer

Who this might be right for
Prostate CancerMetastatic Prostate Cancer
Washington University School of Medicine 30
Post-approval studies (Phase 4)Looking for participantsNCT06706921
What this trial is testing

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

Who this might be right for
Prostatic NeoplasmsProstatic Neoplasms, Castration-ResistantMetastatic Prostate Cancer+8 more
VA Greater Los Angeles Healthcare System 15
Early research (Phase 1)Study completedNCT02458716
What this trial is testing

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate CarcinomaMetastatic Prostatic AdenocarcinomaProstate Carcinoma Metastatic to the Bone
Rutgers, The State University of New Jersey 26
Not applicableStudy completedNCT00578409
What this trial is testing

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 758
Not applicableNot Yet RecruitingNCT06136377
What this trial is testing

Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

Who this might be right for
Patients With Metastatic Castration-resistant Prostate Cancer
Centre Georges Francois Leclerc 35
Early research (Phase 1)Looking for participantsNCT05800665
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer

Who this might be right for
Advanced Prostate CancerMetastatic Prostate Cancer
Genentech, Inc. 210
Not applicableStudy completedNCT02380274
What this trial is testing

Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate CancerCastration-resistant Prostate CancerMetastatic Prostate Cancer
Astellas Pharma Global Development, Inc. 1,030
Not applicableWithdrawnNCT02206724
What this trial is testing

Prospective Evaluation of Stereotactic Body Radiotherapy for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sharp HealthCare
Next Page